Scientists have long known that psychedelics like LSD can help the brain grow new connections. These drugs promote something called neuroplasticity, which helps the brain heal from mental illness. But ...
A growing body of neuroimaging research is pinpointing exactly how psychedelic drugs hijack the brain’s visual system to produce vivid hallucinations, even when a person’s eyes are closed. Studies ...
Psychedelics such as LSD and psilocybin from “magic mushrooms” have been proposed to ease depression. But the hallucination side effect makes these powerful drugs less ideal as therapeutics. Now, ...
A team of neuroscientists and psychologists at École Polytechnique Fédérale de Lausanne, working with a colleague from University Savoie Mont Blanc, CNRS, LPNC, has found that it is possible to induce ...
New treatments for mental health and behavioral disorders are desperately needed. Rates of depression, anxiety, PTSD, and substance use disorders soared during the pandemic, and traditional ...
This article was originally published on Psychedelic Spotlight and appears here with permission. New study suggests that a non-hallucinogenic LSD analog may hold therapeutic potential for mood ...
Current drug therapies for treating depression, anxiety, and other major psychiatric disorders provide limited benefits for most patients and are associated with significant side effects that limit ...
LSD (lysergic acid diethylamide) is one of the most well-known psychedelics. It’s a synthetic compound that was first synthesized in 1938 by Swiss chemist Albert Hofmann. LSD is one of the most potent ...
Hosted on MSN
Neuroscientists tracked brains on psychedelics in real time to finally uncover how visual hallucinations happen
Tripping on psychedelics is hard to describe to someone who’s never been through the experience. Every psychedelic trip is unpredictable and intense, but what seems to be shared across different ...
Psychedelics Without Hallucinations? Study Identifies Possible Antidepressants In LSD-Like Molecules
Brian Roth, a psychiatrist and pharmacology researcher at the University of North Carolina, explained that determining if patients are fit for psychedelic therapies to ward away “bad trips” can be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results